Viela Bio Stock Price - VIE

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Viela Bio Inc VIE NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -1.15 -4.1% 26.93 28.77 26.89 28.77 28.08 11:09:01
Bid Price Ask Price Spread Spread % News
26.41 27.67 1.26 4.55% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
169 7,751 $ 27.96 $ 216,707 175,059 18.20 - 33.6985
Last Trade Time Type Quantity Stock Price Currency
11:08:48 41 $ 26.94 USD

Viela Bio Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.38B 49.27M -8.00 - 49.27M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Viela Bio News

Date Time Source News Article
10/09/201906:00GlobeNewswire Inc.Viela Bio Enters Strategic Collaboration with Mitsubishi..
10/07/201916:05GlobeNewswire Inc.Viela Bio Announces Closing of Initial Public Offering and..
10/02/201921:54GlobeNewswire Inc.Viela Bio Announces Pricing of Initial Public Offering

Latest VIE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VIE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week24.9733.698524.4630.9086,5631.967.85%
1 Month20.7433.698519.0124.6870,0886.1929.85%
3 Months21.5033.698518.2022.24163,1295.4325.26%
6 Months21.5033.698518.2022.24163,1295.4325.26%
1 Year21.5033.698518.2022.24163,1295.4325.26%
3 Years21.5033.698518.2022.24163,1295.4325.26%
5 Years21.5033.698518.2022.24163,1295.4325.26%

Viela Bio Description

Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Your Recent History
Viela Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191114 16:24:03